Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Latest News about Recursion Pharmaceuticals LLC
Recent news which mentions Recursion Pharmaceuticals LLC
Cramer's Lightning Round: Rigetti Computing is 'a meme stock'
March 07, 2025
Tags
Investing
Stock markets
Markets
From
CNBC.com News
Cramer's Lightning Round: Reddit is 'fabulous'
November 26, 2024
Tags
Stock Picks
Business News
S&P 500
From
CNBC.com News
Recursion gets FDA approval to begin phase 1 trials of AI-discovered cancer treatment
October 02, 2024
Tags
Technology
AI / Artificial Intelligence
Health care industry
From
CNBC.com News
Cramer's Lightning Round: 'Hold on to' Marvell Technology
June 27, 2024
Tags
Business
U/S/ Markets
GameStop Corp
From
CNBC.com News
Cramer's Lightning Round: 'I would not be a buyer' of Corning
May 22, 2024
Tags
Merit Medical Systems Inc
Mad Money
Corning Inc
From
CNBC.com News
Recursion Pharmaceuticals CEO explains how AI could make drug development faster and less costly
May 10, 2024
Tickers
CEO
Tags
Stock Picks
Business News
Investment Strategy
From
CNBC.com News
Cramer's Lightning Round: Broadcom is a buy
April 23, 2024
Tags
Investing
Stock markets
Markets
From
CNBC.com News
Nvidia's AI ambitions in medicine and health care are becoming clear
March 24, 2024
Tags
Technology
AI / Artificial Intelligence
Health care industry
From
CNBC.com News
Nvidia holdings disclosure pumps up shares of small AI companies
February 15, 2024
Tags
Artificial intelligence
Microsoft Corp
Nano/X Imaging Ltd
From
CNBC.com News
Top Wall Street analysts pick these stocks for solid returns
January 21, 2024
Tags
Investment strategy
Amgen Inc
U/S/ Markets
From
CNBC.com News
Nvidia invests $50 million in biotech company Recursion for AI drug discovery
July 12, 2023
Tags
Biotechnology
NVIDIA Corp
Companies
From
CNBC.com News
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.